JBM (Healthcare) (HKSE:02161) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02161 JBM (Healthcare) Ltd HKSE:02161
86 GF Score
Price HK$1.94
GF Value HK$2.08
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is JBM (Healthcare) Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:02161 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JBM (Healthcare) Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s Short Interest distribution charts can be found below:

* The bar in red indicates where JBM (Healthcare)'s Short Interest falls into.


HKSE:02161
86GF Score
JBM (Healthcare) Ltd HKSE:02161
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is JBM (Healthcare) (HKSE:02161) Overvalued in 2026?

Based on GuruFocus' analysis, JBM (Healthcare) stock appears to be undervalued. The current stock price of HK$1.94 is trading 6.7% below its estimated GF Value™ of HK$2.08. GuruFocus considers JBM (Healthcare) to be Fairly Valued.

Key valuation signals for HKSE:02161:

  • Short Interest:
  • GF Value™: HK$2.08 vs. price of HK$1.94 (6.7% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JBM (Healthcare) Business Description

Address 108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
86GF Score

Get the complete analysis for HKSE:02161

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.94
Price
HK$2.08
GF Value